Pelthos Therapeutics (PTHS) Goodwill (2025 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Goodwill of $24.7 million for Q4 2025, down 19.41% quarter-over-quarter from $30.6 million in Q3 2025.

Pelthos Therapeutics (PTHS) Goodwill (2025 - 2026) Analysis & Trends

Pelthos Therapeutics' Goodwill history runs 1 years deep, the most recent figure standing at $24.7 million for Q4 2025.

In Q4 2025, Goodwill changed N/A year-over-year to $24.7 million; the TTM figure through Dec 2025 stood at $24.7 million (changed N/A YoY), while the FY2025 annual figure was $24.7 million, changed N/A from the prior year.
Goodwill for Q4 2025 stood at $24.7 million, down from $30.6 million in the prior quarter.
The five-year high for Goodwill was $30.6 million in Q3 2025, with the low at $24.7 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Pelthos Therapeutics	96.56 Mn	72.00 Mn	21.23 Mn

Download Data